Regeneron and Sanofi Restructure Immuno-Oncology Collaboration for Discovery and Development Programs
Regeneron Pharmaceuticals, Inc. and Sanofi have restructured their global Immuno-oncology Discovery and Development Agreement for...
GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to a Diagnostic Assay...
LabCorp, a leading global life sciences company, and GENFIT , a biopharmaceutical company focused on...
Propanc Biopharma Commences Drug Discovery Research Collaboration
Propanc Biopharma, Inc , a clinical stage biopharmaceutical company focused on development of new and...
Stem Cell Medicine Licenses Exosome Technology for Treating Autism from Ramot at Tel Aviv...
Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications, including...
Injecting New Blood into the Life Sciences Innovation Process
Innovation and collaboration are the lifeblood of the life sciences. Without them, both research and...
Transforming The Life Sciences Supply Chain Through Blockchain
Imagine the Possibilities: What if innovations in the life sciences supply chain kept up with...
The need of innovation in the injectable business – a CDMO perspective
The world of drug development and manufacturing is undergoing a change. Nowhere is this more...
Speed, Quality and Cost – Leveraging Australia to Expedite Clinical Development
In recent years, the pharmaceutical industry has seen tremendous changes in the way it is...
Predicting the future of cancer immunotherapy: Using autoantibody biomarkers to drive safer and more...
For a number of years now, immunotherapy has been seen as the dawn of a...
KemPharm Enhances Pipeline with the Addition of KP879, a Potential New Treatment for Stimulant...
KemPharm, Inc. , a specialty pharmaceutical company focused on the discovery and development of proprietary...
